Test Price
2,800 AED✅ Home Collection Available
GDNF Gene Congenital Central Hypoventilation Syndrome (CCHS) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Diagnostic Precision: 99.9% Analytical Sensitivity via ISO 15189/ISO 9001:2015 Accredited NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by DHA-licensed genetics expert.
- Insurance Support: Direct Billing Verification via WhatsApp +971 54 548 8731.
- Price: 2,800 AED (including GST, genetic counseling, and courier logistics).
Test Overview & Methodology
This NGS-based genetic test identifies pathogenic variants in the GDNF gene to confirm congenital central hypoventilation syndrome (CCHS), a rare life-threatening disorder of autonomic respiratory control. Comprehensive sequencing of all coding exons and flanking intronic regions is performed to detect single nucleotide variants, small insertions/deletions, and copy number variations with >99.9% analytical sensitivity.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next-Generation Sequencing with complete gene coverage and CNV detection | Single-gene Sanger sequencing of limited coding regions |
| Analytical Sensitivity | >99.9% for SNVs, indels, and copy-number variants | ~95% for known point mutations; misses large rearrangements |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocols
“A GDNF gene result must always be correlated with the child’s clinical presentation, polysomnography, and autonomic testing. I advise families that a variant of uncertain significance requires careful multidisciplinary follow-up, never immediate treatment decisions. Molecular confirmation enables precise genetic counseling and cascade testing of at-risk relatives.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Safety Advisory & Pre-Test Precautions
Mandatory Pre-Test Screening
- Do not proceed with sample collection if the patient is in acute respiratory failure requiring ICU admission – prioritize emergency stabilization.
- For pediatric patients, confirm that the child is clinically stable for outpatient phlebotomy.
- All sampling is conducted under the framework of Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring patient safety and informed consent.
- If the patient develops new-onset cyanosis, severe bradycardia, or prolonged apneic spells, seek emergency department evaluation before arranging any diagnostic testing.
Exclusion Criteria & Red Flags
Contraindications for Home Collection
- Exclusion: Acute respiratory distress, hemodynamic instability, or active sepsis.
- Legal Mandate: Genetic testing in minors requires valid parental consent in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Red Flag: New-onset cyanosis, severe bradycardia, or prolonged apneic spells – prioritize emergency care.
- Data Privacy: All genetic information is handled in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL); your data is never shared without explicit written consent.
Patient FAQ & Clinical Guidance
1. What is the clinical utility of the GDNF gene test for CCHS?
The test provides definitive molecular confirmation of congenital central hypoventilation syndrome, enabling precise genetic counselling, anticipatory management of hypoventilation, and cascade testing of at-risk relatives. A positive result confirms the diagnosis; a negative result does not rule out CCHS caused by variants in other genes such as PHOX2B.
2. How should I prepare my child for the blood sample collection at home?
Ensure your child is well-hydrated and comforted; a paediatric-trained phlebotomist will use age-appropriate techniques, and you will receive detailed pre-instructions via WhatsApp prior to the home visit. The collection takes approximately 10–15 minutes and requires 3–5 mL of peripheral whole blood in an EDTA tube.
3. How long does it take to receive results and how are they interpreted?
Results are ready in 3 to 4 weeks; a DHA-licensed clinical geneticist will call you to explain the genomic report in the context of your child's overall clinical picture. A telephonic consultation is included in the test price to review variant classification, inheritance pattern, and implications for family members.
4. Is home collection safe for a child with respiratory concerns?
VIP Mobile Phlebotomy is available for clinically stable patients. If your child requires supplemental oxygen, has a tracheostomy, or exhibits any signs of respiratory distress, sample collection will be deferred and you will be directed to a hospital setting. Our team performs a pre-visit triage assessment over the phone to confirm eligibility.
UAE Regulatory & Data Privacy Adherence
Trust & Compliance Framework
- Data Protection: All genetic data is processed under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL). Your genomic information is encrypted, access-controlled, and never shared with third parties without explicit written consent.
- Health Information Governance: Full compliance with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, ensuring secure electronic health record handling.
- Clinical Safety: All diagnostic procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, guaranteeing patient safety and informed consent protocols throughout the testing pathway.
- Accreditations: ISO 15189 and ISO 9001:2015 certified laboratory processes with accreditation number INT/EGQ/2509DA/3139.
- DHA Oversight: Licensed and regulated by the Dubai Health Authority under facility license number 1143.
Clinical & Logistical Metadata
| Test Name | GDNF Gene Congenital Central Hypoventilation Syndrome (CCHS) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM) |
| Methodology Used | Next-Generation Sequencing (NGS) with full gene coverage, CNV detection, and bioinformatic variant annotation |
| ICD-10-CM Code | G47.35 (Congenital central alveolar hypoventilation syndrome) |
| LOINC Code | 21663-5 (GDNF gene mutation analysis in Blood or Tissue by Molecular genetics method) |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians